Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2016

Pages: 82 Published: October 01, 2016 Report Code: GDHC3837CTIDB

  • Overview
  • Key Players
  • Contents
  • Tables
  • Figures
  • Listen
    Powered by iSpeech

GlobalData's clinical trial report, “Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2016" provides an overview of Nonerosive Reflux Disease (NERD) clinical trials scenario. This report provides top line data relating to the clinical trials on Nonerosive Reflux Disease (NERD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Key Players

Takeda Pharmaceutical Company Limited

AstraZeneca Plc

Eisai Co., Ltd.

Sucampo Pharmaceuticals, Inc.

Mitsubishi Chemical Holdings Corporation

Lupin Limited

Dr. Falk Pharma GmbH

CJ CheilJedang Corp.

Ahn-Gook Pharmaceutical Co., Ltd.

Advanced Specialty Care

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Nonerosive Reflux Disease (NERD) to Gastrointestinal Clinical Trials 15

Clinical Trials by Phase in G7 Countries 17

Clinical Trials in G7 Countries by Trial Status 18

Clinical Trials by E7 Countries: Proportion of Nonerosive Reflux Disease (NERD) to Gastrointestinal Clinical Trials 19

Clinical Trials by Phase in E7 Countries 21

Clinical Trials in E7 Countries by Trial Status 22

Clinical Trials by Phase 23

In Progress Trials by Phase 24

Clinical Trials by Trial Status 25

Clinical Trials by End Point Status 26

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials 31

Prominent Drugs 33

Clinical Trial Profile Snapshots 34

Appendix 79

Abbreviations 79

Definitions 79

Research Methodology 80

Secondary Research 80

About GlobalData 81

Contact Us 81

Disclaimer 81

Source 82

List of Tables

Nonerosive Reflux Disease (NERD) Therapeutics, Global, Clinical Trials by Region, 2016* 6

Nonerosive Reflux Disease (NERD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Nonerosive Reflux Disease (NERD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9

Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10

Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11

Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12

Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13

Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14

Proportion of Nonerosive Reflux Disease (NERD) to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 15

Nonerosive Reflux Disease (NERD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17

Nonerosive Reflux Disease (NERD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18

Proportion of Nonerosive Reflux Disease (NERD) to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 19

Nonerosive Reflux Disease (NERD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21

Nonerosive Reflux Disease (NERD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 22

Nonerosive Reflux Disease (NERD) Therapeutics, Global, Clinical Trials by Phase, 2016* 23

Nonerosive Reflux Disease (NERD) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 24

Nonerosive Reflux Disease (NERD) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 25

Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 26

Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 27

Nonerosive Reflux Disease (NERD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 28

Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 29

Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 31

Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 33

List of Figures

Nonerosive Reflux Disease (NERD) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6

Nonerosive Reflux Disease (NERD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Nonerosive Reflux Disease (NERD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9

Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10

Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11

Proportion of Nonerosive Reflux Disease (NERD) to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 15

Nonerosive Reflux Disease (NERD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17

Nonerosive Reflux Disease (NERD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18

Proportion of Nonerosive Reflux Disease (NERD) to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 19

Nonerosive Reflux Disease (NERD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21

Nonerosive Reflux Disease (NERD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 22

Nonerosive Reflux Disease (NERD) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 23

Nonerosive Reflux Disease (NERD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 24

Nonerosive Reflux Disease (NERD) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 25

Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 26

Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 27

Nonerosive Reflux Disease (NERD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 28

Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 29

Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 31

Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 33

GlobalData Methodology 80

$2500

Can be used by individual purchaser only

$7500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.